Search results
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 4 days agoThe data are yet to be submitted for publication in a peer-reviewed journal, but the company says...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 1 day agoModerna has announced that its Phase III clinical trial of the investigational next-generation...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 4 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 5 days agoMock said Moderna used a new antigen in its updated Covid vaccine to help focus on newer strains....
Moderna COVID/flu combo vaccine superior to separate shots in trial
KFGO· 5 days agoBy Patrick Wingrove (Reuters) - Moderna said on Monday its combination vaccine to protect against...
Moderna's COVID-Flu Vaccine Shows Stronger Immune Response Than Individual Shots, Late-Stage Trial...
Forbes· 5 days agoModerna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 5 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 5 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Moderna’s COVID, flu combination vaccine shows stronger immune response, company announces
WHIO-TV 7 Dayton· 5 days agoModerna is working on a single vaccine that it says will protect people against both COVID-19 and...
Moderna's mRNA-1283 vaccine shows promise in Phase 3 trial By Investing.com
Investing.com· 2 days agoModerna , Inc. (NASDAQ:MRNA) has announced successful results from the Phase 3 trial of its...